FDA Risk Communication Plan May Be Released Within A Month
This article was originally published in The Gray Sheet
Executive Summary
FDA's strategic plan for ensuring the public receives accurate and balanced information about the risks and benefits of medical products could be released within a month, according to FDA Center for Drug Evaluation and Research Director Janet Woodcock